<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2025-340</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-9416</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЗАБОЛЕВАНИЯ КОЖИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>DERMAL DISEASES</subject></subj-group></article-categories><title-group><article-title>Акне: выявление ключевых факторов и лечение фиксированной комбинацией «адапален + метронидазол»</article-title><trans-title-group xml:lang="en"><trans-title>Revealing the key factors associated with acne development and treatment with a fixed combination adapalene + metronidazole</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7781-7786</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хисматулина</surname><given-names>И. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Khismatulina</surname><given-names>I. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хисматулина Ирина Мансуровна - к.м.н., доцент кафедры дерматовенерологии, Казанский государственный медицинский университет; врач-дерматовенеролог, ООО «Здоровье семьи 1».</p><p>420012 Казань, ул. Бутлерова, д. 49; 420124, Казань, ул. Чистопольская, д. 15</p></bio><bio xml:lang="en"><p>Irina M. Khismatulina - Cand. Sci. (Med.), Associate Professor of the Department of Dermatovenerology, Kazan State Medical University; Dermatovenerologist, Family Health 1 LLC;</p><p>49, Butlerov St., Kazan, 420012; 15, Chistopolskaya St., Kazan, 420124</p></bio><email xlink:type="simple">xomenko-aa@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4377-2567</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лисовская</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Lisovskaya</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лисовская Светлана Анатольевна - к.б.н., доцент кафедры микробиологии, Казанский ГМУ; старший научный сотрудник лаборатории микологии, Казанский НИИ эпидемиологии и микробиологии; старший научный сотрудник научно-исследовательской лаборатории генетики микроорганизмов Института фундаментальной медицины и биологии, Казанский (Приволжский) федеральный университет.</p><p>420012, Казань, ул. Бутлерова, д. 49; 420015, Казань, ул. Большая Красная, д. 67; 420008, Казань, ул. Кремлевская, д. 18, стр. 1</p></bio><bio xml:lang="en"><p>Svetlana A. Lisovskaya - Cand. Sci. (Biol.), Associate Professor of the Department of Microbiology, Kazan SMU; Senior Researcher at the Department of Mycology, Kazan Scientific Research Institute of Epidemiology and Microbiology; Kazan Scientific Research Institute of Epidemiology and Microbiology.</p><p>49, Butlerov St., Kazan, 420012; 67, Bolshaya Krasnaya St., Kazan, 420015</p></bio><email xlink:type="simple">s_lisovskaya@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Герман</surname><given-names>Я. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>German</surname><given-names>Ya. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Герман Яна Эдуардовна - к.м.н., доцент кафедры акушерства и гинекологии, Казанская ГМА, главный врач, ООО «Здоровье семьи 1».</p><p>420012, Казань, ул. Бутлерова, д. 36; 420124, Казань, ул. Чистопольская, д. 15</p></bio><bio xml:lang="en"><p>Yana E. German - Cand. Sci. (Med.), Associate Professor of the Department of Obstetrics and Gynecology, Kazan State Medical Academy; Chief Medical Officer, Family Health 1 LLC;</p><p>36, Butlerov St., Kazan, 420012; 15, Chistopolskaya St., Kazan, 420124</p></bio><email xlink:type="simple">yanak77@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4227-008X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кравцова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kravtsova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кравцова Ольга Александровна - к.б.н., доцент кафедры биохимии, биотехнологии и фармакологии Института фундаментальной медицины и биологии.</p><p>420008, Казань, ул. Кремлевская, д. 18, стр. 1</p></bio><bio xml:lang="en"><p>Olga A. Kravtsova - Cand. Sci. (Biol.), Associate Professor of the Department of Biochemistry, Biotechnology and Pharmacology, Institute of Fundamental Medicine and Biology.</p><p>18, Bldg. 1, Kremlevskaya St., Kazan, 420008</p></bio><email xlink:type="simple">okravz@yandex.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9869-4909</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Синица</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Sinitca</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Синица Александр Михайлович - старший научный сотрудник кафедры радиотехнических систем.</p><p>197022, Санкт-Петербург, ул. Профессора Попова д. 5ф</p></bio><bio xml:lang="en"><p>Aleksandr M. Sinitca - Senior Researcher at the Department of Radio Engineering Systems.</p><p>5f, Professor Popov St., St Petersburg, 197022</p></bio><email xlink:type="simple">amsinitca@etu.ru</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0356-5651</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богачев</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogachev</surname><given-names>M. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Богачев Михаил Игоревич - д.т.н., доцент, главный научный сотрудник кафедры радиотехнических систем.</p><p>197022, Санкт-Петербург, ул. Профессора Попова, д. 5ф</p></bio><bio xml:lang="en"><p>Mikhail I. Bogachev - Dr. Sci. (Eng.), Associate Professor, Principal Researcher at the Department of Radio Engineering Systems.</p><p>5f, Professor Popov St., St Petersburg, 197022</p></bio><email xlink:type="simple">mibogachey@etu.ru</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7195-1557</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каюмов</surname><given-names>А. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Kayumov</surname><given-names>A. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каюмов Айрат Рашитович - д.б.н., доцент, заведующий кафедрой генетики Института фундаментальной медицины и биологии.</p><p>420008, Казань, ул. Кремлевская, д. 18, стр. 1</p></bio><bio xml:lang="en"><p>Airat R. Kayumov - Dr. Sci. (Biol.), Associate Professor, Head of Department of Genetics at the Institute of Fundamental Medicine and Biology.</p><p>18, Bldg. 1, Kremlevskaya St., Kazan, 420008</p></bio><email xlink:type="simple">kairatr@yandex.ru</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Казанский государственный медицинский университет; ООО «Здоровье семьи 1»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kazan State Medical University; Family Health 1 LLC</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Казанский государственный медицинский университет; Казанский научно-исследовательский институт эпидемиологии и микробиологии; Казанский (Приволжский) федеральный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kazan State Medical University; Kazan Scientific Research Institute of Epidemiology and Microbiology; Kazan Federal University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ООО «Здоровье семьи 1»; Казанская государственная медицинская академия</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Family Health 1 LLC; Kazan State Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Казанский (Приволжский) федеральный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kazan Federal University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>Санкт-Петербургский государственный электротехнический университет «ЛЭТИ»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>St Petersburg Electrotechnical University “LETI”</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>30</day><month>09</month><year>2025</year></pub-date><volume>0</volume><issue>14</issue><fpage>125</fpage><lpage>135</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Хисматулина И.М., Лисовская С.А., Герман Я.Э., Кравцова О.А., Синица А.М., Богачев М.И., Каюмов А.Р., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Хисматулина И.М., Лисовская С.А., Герман Я.Э., Кравцова О.А., Синица А.М., Богачев М.И., Каюмов А.Р.</copyright-holder><copyright-holder xml:lang="en">Khismatulina I.M., Lisovskaya S.A., German Y.E., Kravtsova O.A., Sinitca A.M., Bogachev M.I., Kayumov A.R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/9416">https://www.med-sovet.pro/jour/article/view/9416</self-uri><abstract><sec><title>Введение</title><p>Введение. Поиск эффективного подхода к лечению аcne vulgaris затрудняется сложным взаимодействием факторов, влияющих на течение и исход заболевания.</p></sec><sec><title>Цель</title><p>Цель. Выявить ключевые ассоциации факторов развития и тяжести течения акне с помощью реконструкции байесовской сети и сделать анализ результатов лечения фиксированной комбинацией адапален 0,1% + метронидазол 1%, гель.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Исследование проводилось с 2023 по 2025 г. в г. Казани, были включены 650 пациентов с акне, средний возраст – 23,0 ± 3,7 года. Изучаемые параметры включали: неизменяемые (общие характеристики, данные анамнеза) и изменяемые (лабораторные показатели, морфофункциональные параметры и состав микробиоты кожи лица) факторы. Полученными параметрами стали клинические характеристики и дерматологические индексы. На первом этапе была реконструирована непараметрическая байесовская сеть. На втором этапе была выделена группа пациентов с акне легкой и средней степени (n = 56), которой проведено лечение гелем адапален 0,1% + метронидазол 1% (препарат Метрогил® А)в течение 12 нед.</p></sec><sec><title>Результаты</title><p>Результаты. Наружная терапия в группе пациентов с акне легкой и средней степени, имевших нарушения микробиома кожи лица (n = 56), препаратом адапален 0,1% + метронидазол 1%, гель была эффективна: клиническая ремиссия наступила у 60,7% (n = 34), значительное улучшение – у 37,5% (n = 21). Нежелательные местные реакции характеризовались легкой степенью выраженности и не требовали отмены препарата.</p></sec><sec><title>Выводы</title><p>Выводы. Представленный подход полезен для визуализации сложных взаимосвязей между факторами и клиническими исходами при анализе мультифакториальных заболеваний. Основанная на результатах анализа наружная терапия акне (адапален 0,1% + метронидазол 1%, гель) в группе пациентов, имевших нарушения микробиома кожи лица, показала эффективность, безопасность и хорошую переносимость.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. The search for an effective approach to the treatment of аcne vulgaris is complicated by the complex interaction of factors influencing the course and outcome of the disease.</p></sec><sec><title>Aim</title><p>Aim. To identify key associations of acne development factors and severity by reconstructing a Bayesian network and analyzing the results of treatment with a fixed combination of adapalene 0.1% + metronidazole 1% (Metrogyl® A gel).</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The study was conducted from 2023 to 2025 in Kazan, 650 patients with acne were included, the average age was 23 ± 3.7 years. The independent parameters included: general characteristics, medical history, various clinical parameters depending on independent ones included: laboratory parameters, morphofunctional parameters and composition of the microbiota of the facial skin. The resulting parameters of the model were clinical characteristics and dermatological indices. At the first stage, a nonparametric Bayesian network was reconstructed. At the second stage, a group of patients with mild to moderate acne (n = 56) were treated with adapalene 0.1% + metronidazole 1% gel for 12 weeks.</p></sec><sec><title>Results</title><p>Results. The factors influencing the development and course of acne were identified, and two clusters of highly related features that describe the influence of hormone-associated and microbial pathogenesis factors were formed. Topical therapy in the group of patients with mild and moderate acne who had disorders of the skin microbiome (n = 56) with adapalene 0.1% + metronidazole 1% gel was effective: сlinical remission occurred in 60.7% (n = 34), significant improvement in 37.5% (n = 21). Local adverse reactions were characterized by mild severity and did not require drug withdrawal.</p></sec><sec><title>Conclusions</title><p>Conclusions. The present approach is useful for visualization of complicated relationships between factors and clinical outcomes for analysis of complex relationships between factors and clinical outcomes in the analysis of multifactorial diseases. Based on the results of the analysis, topical acne therapy (adapalene 0.1% + metronidazole 1%, gel) in a group of patients with skin microbiome disorders showed efficacy, safety and good tolerability.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>акне</kwd><kwd>мультифакториальный дерматоз</kwd><kwd>байесовская сеть</kwd><kwd>морфофункциональные параметры кожи лица</kwd><kwd>микробиом кожи лица</kwd><kwd>топическая терапия</kwd><kwd>комбинации адапалена</kwd><kwd>метронидазол</kwd><kwd>адапален</kwd></kwd-group><kwd-group xml:lang="en"><kwd>acne</kwd><kwd>multifactorial dermatosis</kwd><kwd>Bayesian network</kwd><kwd>morphofunctional parameters of facial skin</kwd><kwd>microbiome of facial skin</kwd><kwd>topical therapy</kwd><kwd>adapalene combinations</kwd><kwd>metronidazole</kwd><kwd>adapalene</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при финансовой поддержке Российского научного фонда, грант №24-14-00194. Авторы выражают благодарность ООО «Юник Фармасьютикал Лабораториз» за содействие в публикации статьи</funding-statement><funding-statement xml:lang="en">This research was funded by the Russian Science Foundation (grant No. 24-14-00194). The authors express their gratitude to Unique Pharmaceutical Laboratories LLC for their assistance in publishing the article</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Chen H, Zhang T, Yin X, Man J, Yang X, Lu M. Magnitude and temporal trend of acne vulgaris burden in 204 countries and territories from 1990 to 2019: an analysis from the Global Burden of Disease Study 2019. Br J Dermatol. 2022;186(4):673–683. https://doi.org/10.1111/bjd.20882.</mixed-citation><mixed-citation xml:lang="en">Chen H, Zhang T, Yin X, Man J, Yang X, Lu M. Magnitude and temporal trend of acne vulgaris burden in 204 countries and territories from 1990 to 2019: an analysis from the Global Burden of Disease Study 2019. Br J Dermatol. 2022;186(4):673–683. https://doi.org/10.1111/bjd.20882.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Reynolds RV, Yeung H, Cheng CE, Cook-Bolden F, Desai SR, Druby KM et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1–1006.e30. https://doi.org/10.1016/j.jaad.2023.12.017.</mixed-citation><mixed-citation xml:lang="en">Reynolds RV, Yeung H, Cheng CE, Cook-Bolden F, Desai SR, Druby KM et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1–1006.e30. https://doi.org/10.1016/j.jaad.2023.12.017.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Chinese Guidelines for the Management of Acne Vulgaris: 2019 Update. Int J Dermatol Venereol. 2019;2(3):129–137. https://doi.org/10.1097/jD9.0000000000000043.</mixed-citation><mixed-citation xml:lang="en">Chinese Guidelines for the Management of Acne Vulgaris: 2019 Update. Int J Dermatol Venereol. 2019;2(3):129–137. https://doi.org/10.1097/jD9.0000000000000043.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Nast A, Dréno B, Bettoli V, Bukvic Mokos Z, Degitz K, Dressler C et al. European evidence based (S3) guideline for the treatment of acne – update 2016 – short version. J Eur Acad Dermatol Venereol. 2016;30(8):1261–1268. https://doi.org/10.1111/jdv.13776.</mixed-citation><mixed-citation xml:lang="en">Nast A, Dréno B, Bettoli V, Bukvic Mokos Z, Degitz K, Dressler C et al. European evidence based (S3) guideline for the treatment of acne – update 2016 – short version. J Eur Acad Dermatol Venereol. 2016;30(8):1261–1268. https://doi.org/10.1111/jdv.13776.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Mallon E, Newton J, Klassen A, Stewart-Brown SL, Ryan T, Finlay A. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;140(4):672–676. https://doi.org/10.1046/j.1365-2133.1999.02768.x.</mixed-citation><mixed-citation xml:lang="en">Mallon E, Newton J, Klassen A, Stewart-Brown SL, Ryan T, Finlay A. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;140(4):672–676. https://doi.org/10.1046/j.1365-2133.1999.02768.x.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cresce ND, Davis SA, Huang WW, Feldman SR. The quality of life impact of acne and rosacea compared to other major medical conditions. J Drugs Dermatol. 2014;13(6):692–697. Available at: https://pubmed.ncbi.nlm.nih.gov/24918559.</mixed-citation><mixed-citation xml:lang="en">Cresce ND, Davis SA, Huang WW, Feldman SR. The quality of life impact of acne and rosacea compared to other major medical conditions. J Drugs Dermatol. 2014;13(6):692–697. Available at: https://pubmed.ncbi.nlm.nih.gov/24918559.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Eichenfield DZ, Sprague J, Eichenfield LF. Management of acne vulgaris: a review. JAMA. 2021;326(20):2055–2067. https://doi.org/10.1001/jama.2021.17633.</mixed-citation><mixed-citation xml:lang="en">Eichenfield DZ, Sprague J, Eichenfield LF. Management of acne vulgaris: a review. JAMA. 2021;326(20):2055–2067. https://doi.org/10.1001/jama.2021.17633.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ju Q, Tao T, Hu T, Karadağ AS, Al-Khuzaei S, Chen W. Sex hormones and acne. Clin Dermatol. 2017;35(2):130–137. https://doi.org/10.1016/j.clindermatol.2016.10.004.</mixed-citation><mixed-citation xml:lang="en">Ju Q, Tao T, Hu T, Karadağ AS, Al-Khuzaei S, Chen W. Sex hormones and acne. Clin Dermatol. 2017;35(2):130–137. https://doi.org/10.1016/j.clindermatol.2016.10.004.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Heng AHS, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020;10(1):5754. https://doi.org/10.1038/s41598-02062715-3.</mixed-citation><mixed-citation xml:lang="en">Heng AHS, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020;10(1):5754. https://doi.org/10.1038/s41598-02062715-3.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Holland DB, Jeremy A. The role of inflammation in the pathogenesis of acne and acne scarring. Semin Cutan Med Surg. 2005;24(2):79–83. https://doi.org/10.1016/j.sder.2005.03.004.</mixed-citation><mixed-citation xml:lang="en">Holland DB, Jeremy A. The role of inflammation in the pathogenesis of acne and acne scarring. Semin Cutan Med Surg. 2005;24(2):79–83. https://doi.org/10.1016/j.sder.2005.03.004.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Dréno B, Bettoli V, Araviiskaia E, Sanchez Viera M, Bouloc A. The influence of exposome on acne. J Eur Acad Dermatol Venereol. 2018;32(5):812–819. https://doi.org/10.1111/jdv.14820.</mixed-citation><mixed-citation xml:lang="en">Dréno B, Bettoli V, Araviiskaia E, Sanchez Viera M, Bouloc A. The influence of exposome on acne. J Eur Acad Dermatol Venereol. 2018;32(5):812–819. https://doi.org/10.1111/jdv.14820.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Grice EA, Segre JA. The skin microbiome. Nature Rev Microbiol. 2011;9(4):244–253. https://doi.org/10.1038/nrmicro2537.</mixed-citation><mixed-citation xml:lang="en">Grice EA, Segre JA. The skin microbiome. Nature Rev Microbiol. 2011;9(4):244–253. https://doi.org/10.1038/nrmicro2537.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018;16(3):143–155. https://doi.org/10.1038/nrmicro.2017.157.</mixed-citation><mixed-citation xml:lang="en">Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018;16(3):143–155. https://doi.org/10.1038/nrmicro.2017.157.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Rozas M, Hart de Ruijter A, Fabrega MJ, Zorgani A, Guell M, Paetzold Bet al. From dysbiosis to healthy skin: major contributions of Cutibacterium acnes to skin homeostasis. Microorganisms. 2021;9(3):628. https://doi.org/10.3390/microorganisms9030628.</mixed-citation><mixed-citation xml:lang="en">Rozas M, Hart de Ruijter A, Fabrega MJ, Zorgani A, Guell M, Paetzold Bet al. From dysbiosis to healthy skin: major contributions of Cutibacterium acnes to skin homeostasis. Microorganisms. 2021;9(3):628. https://doi.org/10.3390/microorganisms9030628.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cavallo I, Sivori F, Truglio M, De Maio F, Lucantoni F, Cardinali G et al. Skin dysbiosis and Cutibacterium acnes biofilm in inflammatory acne lesions of adolescents. Sci Rep. 2022;12(1):21104. https://doi.org/10.1038/s41598022-25436-3.</mixed-citation><mixed-citation xml:lang="en">Cavallo I, Sivori F, Truglio M, De Maio F, Lucantoni F, Cardinali G et al. Skin dysbiosis and Cutibacterium acnes biofilm in inflammatory acne lesions of adolescents. Sci Rep. 2022;12(1):21104. https://doi.org/10.1038/s41598022-25436-3.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Di Domenico EG, Farulla I, Prignano G, Gallo MT, Vespaziani M, Cavallo I et al. Biofilm is a Major Virulence Determinant in Bacterial Colonization of Chronic Skin Ulcers Independently from the Multidrug Resistant Phenotype. Int J Mol Sci. 2017;18(5):1077. https://doi.org/10.3390/ijms18051077.</mixed-citation><mixed-citation xml:lang="en">Di Domenico EG, Farulla I, Prignano G, Gallo MT, Vespaziani M, Cavallo I et al. Biofilm is a Major Virulence Determinant in Bacterial Colonization of Chronic Skin Ulcers Independently from the Multidrug Resistant Phenotype. Int J Mol Sci. 2017;18(5):1077. https://doi.org/10.3390/ijms18051077.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Dréno B. What is new in the pathophysiology of acne, an overview. J Eur Acad Dermatol Venereol. 2017;(31):8–12. https://doi.org/10.1111/jdv.14374.</mixed-citation><mixed-citation xml:lang="en">Dréno B. What is new in the pathophysiology of acne, an overview. J Eur Acad Dermatol Venereol. 2017;(31):8–12. https://doi.org/10.1111/jdv.14374.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Agak GW, Kao S, Ouyang K, Qin M, Moon D, Butt A et al. Phenotype and antimicrobial activity of Th17 cells induced by Propionibacterium acnes strains associated with healthy and acne skin. J Invest Dermatol. 2018;138(2):316–324. https://doi.org/10.1016/j.jid.2017.07.842.</mixed-citation><mixed-citation xml:lang="en">Agak GW, Kao S, Ouyang K, Qin M, Moon D, Butt A et al. Phenotype and antimicrobial activity of Th17 cells induced by Propionibacterium acnes strains associated with healthy and acne skin. J Invest Dermatol. 2018;138(2):316–324. https://doi.org/10.1016/j.jid.2017.07.842.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Feidenhansl C, Lund M, Poehlein A, Lood R, Lomholt HB, Brüggemann H. Cutibacterium and Staphylococcus dysbiosis of the skin microbiome in acne and its decline after isotretinoin treatment. JEADV Clin Pract. 2024;3(5):1454–1466. https://doi.org/10.1007/s00403-024-03585-x.</mixed-citation><mixed-citation xml:lang="en">Feidenhansl C, Lund M, Poehlein A, Lood R, Lomholt HB, Brüggemann H. Cutibacterium and Staphylococcus dysbiosis of the skin microbiome in acne and its decline after isotretinoin treatment. JEADV Clin Pract. 2024;3(5):1454–1466. https://doi.org/10.1007/s00403-024-03585-x.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Aktaş Karabay E, Aksu Çerman A. Demodex folliculorum infestations in common facial dermatoses: acne vulgaris, rosacea, seborrheic dermatitis. An Bras Dermatol. 2020;95(2):187–193. https://doi.org/10.1016/j.abd.2019.08.023.</mixed-citation><mixed-citation xml:lang="en">Aktaş Karabay E, Aksu Çerman A. Demodex folliculorum infestations in common facial dermatoses: acne vulgaris, rosacea, seborrheic dermatitis. An Bras Dermatol. 2020;95(2):187–193. https://doi.org/10.1016/j.abd.2019.08.023.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Guo Z, Yang Y, Wu Q, Liu M, Zhou L, Zhang L et al. New insights into the characteristic skin microorganisms in different grades of acne and different acne sites. Front Microbiol. 2023;14:1167923. https://doi.org/10.3389/fmicb.2023.1167923.</mixed-citation><mixed-citation xml:lang="en">Guo Z, Yang Y, Wu Q, Liu M, Zhou L, Zhang L et al. New insights into the characteristic skin microorganisms in different grades of acne and different acne sites. Front Microbiol. 2023;14:1167923. https://doi.org/10.3389/fmicb.2023.1167923.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Koot P, Mendoza-Lugo MA, Paprotny D, Morales-Nápoles O, Ragno E, Worm DT. PyBanshee version (1.0): A Python implementation of the MATLAB toolbox BANSHEE for Non-Parametric Bayesian Networks with updated features. SoftwareX. 2023;21:101279. https://doi.org/10.1016/j.softx.2022.101279.</mixed-citation><mixed-citation xml:lang="en">Koot P, Mendoza-Lugo MA, Paprotny D, Morales-Nápoles O, Ragno E, Worm DT. PyBanshee version (1.0): A Python implementation of the MATLAB toolbox BANSHEE for Non-Parametric Bayesian Networks with updated features. SoftwareX. 2023;21:101279. https://doi.org/10.1016/j.softx.2022.101279.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Bogachev MI, Tishin DV, Gafurov AM, Gareev BI, Imaev RG, Kaplun DI et al. The impact of Grey Heron (Ardea cinerea L.) colony on soil biogeochemistry and vegetation: a natural long-term in situ experiment in a planted pine forest. Front Envir Sci. 2023;11:1197657. https://doi.org/10.3389/fenvs.2023.1197657.</mixed-citation><mixed-citation xml:lang="en">Bogachev MI, Tishin DV, Gafurov AM, Gareev BI, Imaev RG, Kaplun DI et al. The impact of Grey Heron (Ardea cinerea L.) colony on soil biogeochemistry and vegetation: a natural long-term in situ experiment in a planted pine forest. Front Envir Sci. 2023;11:1197657. https://doi.org/10.3389/fenvs.2023.1197657.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Weber P, Medina-Oliva G, Simon C, Iung B. Overview on Bayesian networks applications for dependability, risk analysis and maintenance areas. Eng Appl Artif Intell. 2012;25(4):671–682. https://doi.org/10.1016/j.engappai.2010.06.002.</mixed-citation><mixed-citation xml:lang="en">Weber P, Medina-Oliva G, Simon C, Iung B. Overview on Bayesian networks applications for dependability, risk analysis and maintenance areas. Eng Appl Artif Intell. 2012;25(4):671–682. https://doi.org/10.1016/j.engappai.2010.06.002.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Delgado-Hernández D-J, Morales-Nápoles O, De-León-Escobedo D, Arteaga-Arcos J-C. A continuous Bayesian network for earth dams’ risk assessment: an application. Struct Infrast Eng. 2014;10(2):225–238.</mixed-citation><mixed-citation xml:lang="en">Delgado-Hernández D-J, Morales-Nápoles O, De-León-Escobedo D, Arteaga-Arcos J-C. A continuous Bayesian network for earth dams’ risk assessment: an application. Struct Infrast Eng. 2014;10(2):225–238.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Hanea A, Napoles OM, Ababei D. Non-parametric Bayesian networks: Improving theory and reviewing applications. Reliab Eng Syst Saf. 2015;144:265–284. https://doi.org/10.1016/j.ress.2015.07.027.</mixed-citation><mixed-citation xml:lang="en">Hanea A, Napoles OM, Ababei D. Non-parametric Bayesian networks: Improving theory and reviewing applications. Reliab Eng Syst Saf. 2015;144:265–284. https://doi.org/10.1016/j.ress.2015.07.027.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Paprotny D, Morales-Nápoles O. Estimating extreme river discharges in Europe through a Bayesian network. Hydrol Earth Syst Sci. 2017;21(6):2615–2636. https://doi.org/10.5194/hess-21-2615-2017.</mixed-citation><mixed-citation xml:lang="en">Paprotny D, Morales-Nápoles O. Estimating extreme river discharges in Europe through a Bayesian network. Hydrol Earth Syst Sci. 2017;21(6):2615–2636. https://doi.org/10.5194/hess-21-2615-2017.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Cooke RM, Wielicki B. Probabilistic reasoning about measurements of equilibrium climate sensitivity: combining disparate lines of evidence. Clim Change. 2018;151(3):541–554. https://doi.org/10.1007/s10584-018-2315-y.</mixed-citation><mixed-citation xml:lang="en">Cooke RM, Wielicki B. Probabilistic reasoning about measurements of equilibrium climate sensitivity: combining disparate lines of evidence. Clim Change. 2018;151(3):541–554. https://doi.org/10.1007/s10584-018-2315-y.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Terefenko P, Paprotny D, Giza A, Morales-Nápoles O, Kubicki A, Walczakiewicz S. Monitoring cliff erosion with LiDAR surveys and Bayesian network-based data analysis. Remote Sensing. 2019;11(7):843. https://doi.org/10.3390/rs11070843.</mixed-citation><mixed-citation xml:lang="en">Terefenko P, Paprotny D, Giza A, Morales-Nápoles O, Kubicki A, Walczakiewicz S. Monitoring cliff erosion with LiDAR surveys and Bayesian network-based data analysis. Remote Sensing. 2019;11(7):843. https://doi.org/10.3390/rs11070843.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Baba K, Shibata R, Sibuya M. Partial correlation and conditional correlation as measures of conditional independence. Aust New Zealand J Stat. 2004;46(4):657–664. https://doi.org/10.1111/j.1467-842X.2004.00360.x.</mixed-citation><mixed-citation xml:lang="en">Baba K, Shibata R, Sibuya M. Partial correlation and conditional correlation as measures of conditional independence. Aust New Zealand J Stat. 2004;46(4):657–664. https://doi.org/10.1111/j.1467-842X.2004.00360.x.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Baba K, Sibuya M. Equivalence of partial and conditional correlation coefficients. J Japan Stat Society. 2005;35(1):1–19. https://doi.org/10.14490/jjss.35.1.</mixed-citation><mixed-citation xml:lang="en">Baba K, Sibuya M. Equivalence of partial and conditional correlation coefficients. J Japan Stat Society. 2005;35(1):1–19. https://doi.org/10.14490/jjss.35.1.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Хисматулина ИМ, Лисовская СА. Изучение противомикробной активности топических препаратов, применяемых при лечении папулопустулезных дерматозов лица. Клиническая дерматология и венерология. 2023;22(2):181–185. https://doi.org/10.17116/klinderma202322021181.</mixed-citation><mixed-citation xml:lang="en">Khismatulina IM, Lisovskaya SA. Study of antimicrobial activity of topical drugs used in the treatment of papulopustular dermatoses of the face. Klinicheskaya Dermatologiya i Venerologiya. 2023;22(2):181–185. (In Russ.) https://doi.org/10.17116/klinderma202322021181.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
